Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 1/2021

01-01-2021 | Lung Cancer | Thoracic Oncology

The Devil Is in the Details

Author: Frank C. Detterbeck, MD

Published in: Annals of Surgical Oncology | Issue 1/2021

Login to get access

Excerpt

Wankhede1 has performed a systematic review and meta-analysis of studies validating the eighth edition of the tumor-node-metastasis (TNM) classification of lung cancer, which took effect in 2017. It is important to validate that stage classification actually works when applied in different independent datasets. Indeed, the International Association for the Study of Lung Cancer (IASLC) Staging and Prognostic Factors Committee (SPFC) that developed the eighth edition of lung cancer stage classification explicitly called for others to conduct such studies. Therefore, this is an important undertaking, especially because work on the development of revisions to the eighth edition are underway, with the nineth edition scheduled to replace it in 2024. …
Literature
1.
2.
Chansky K, Detterbeck FC, Nicholson AG, et al. The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 2017;12:1109–21.
3.
Yang L, Wang S, Zhou Y, et al. Evaluation of the 7(th) and 8(th) editions of the AJCC/UICC TNM staging systems for lung cancer in a large North American cohort. Oncotarget. 2017;8:66784–95.CrossRef
4.
Detterbeck FC. Stage classification and prediction of prognosis: The difference between accountants and speculators. J Thorac Oncol. 2013;8:820–2.CrossRef
5.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.CrossRef
6.
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.CrossRef
7.
Detterbeck F, Chansky K, Groome P, et al. The IASLC lung cancer staging project: methodology and validation used in the development of proposals for revision of the stage classification of non-small cell lung cancer in the forthcoming (8th) edition of the TNM classification of lung cancer. J Thor Oncol. 2016;11:1433–46.CrossRef
Metadata
Title
The Devil Is in the Details
Author
Frank C. Detterbeck, MD
Publication date
01-01-2021
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 1/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-09263-2

Other articles of this Issue 1/2021

Annals of Surgical Oncology 1/2021 Go to the issue

Gastrointestinal Oncology

Quality-of-Life Assessment in Patients Receiving Palliative Chemotherapy: Call for Action

Breast Oncology

Adoption of SSO-ASTRO Margin Guidelines for Ductal Carcinoma in Situ: What Is the Impact on Use of Additional Surgery?

Gastrointestinal Oncology

The Potential of Lymph Node Yield as a Quality Indicator of Esophagectomy for Esophageal Cancer

Urologic Oncology

Evaluating the Oncological Outcomes of Pure Laparoscopic Radical Nephroureterectomy Performed for Upper-Tract Urothelial Carcinoma Patients: A Multicenter Cohort Study Adjusted by Propensity Score Matching

ASO Author Reflections

ASO Author Reflections: Quality of Life After Gastrectomy for Cancer

Breast Oncology

Breast-Conserving Surgery is Oncologically Safe for Well-Selected, Centrally Located Breast Cancer